Target intelligence / Profile preview

Innate immune pattern recognition receptors and adaptive immune receptors (PRRs and AIRs)

Target
PRRs and AIRs
Molecular classification
Receptor, Pattern recognition receptor, Antigen receptor, Transmembrane protein
01

Overview

Innate immune pattern recognition receptors (PRRs) and adaptive immune receptors represent the two primary sensing systems of the vertebrate immune system. PRRs, including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), are germline-encoded proteins that detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Source: StatPearls, Innate Immunity). In contrast, adaptive immune receptors, specifically T-cell receptors (TCRs) and B-cell receptors (BCRs), are generated through somatic recombination, allowing for the recognition of a vast array of specific antigens (Source: Janeway's Immunobiology). These receptor systems are critical for host defense; however, their overactivation or failure to distinguish self from non-self leads to conditions such as sepsis, rheumatoid arthritis, and systemic lupus erythematosus (Source: Nature Reviews Immunology). Pharmacological intervention targeting these receptors includes the use of TLR agonists like Imiquimod for viral infections and skin cancers, as well as monoclonal antibodies that modulate adaptive signaling, such as Pembrolizumab for oncology (Source: FDA, PubMed). The complexity of these systems presents challenges in drug development, particularly regarding the risk of systemic inflammatory responses or profound immunosuppression.

Other names
Pattern recognition receptorsAntigen receptorsImmune receptorsPRRsAIRsInnate and adaptive immune sensors
02

Mechanism of action

Agonism or antagonism of specific innate or adaptive receptors to modulate immune signaling pathways.

03

Biological functions

Immune responseSignal transductionPathogen recognitionAntigen presentationInflammationCell activation
04

Disease associations

InfectionInflammationAutoimmune diseaseCancerAllergyImmunodeficiency
05

Safety considerations

Cytokine release syndromeImmunosuppressionAutoimmunityInfusion-related reactionImmune-related adverse events (irAEs)
06

Interacting drugs

Imiquimod

8 more in the full profile.

07

Biomarkers

C-reactive proteinInterleukin-6Tumor necrosis factor-alphaCD4+ T-cell countCD8+ T-cell countInterferon-gamma

Beyond the preview

Go deeper on Innate immune pattern recognition receptors and adaptive immune receptors (PRRs and AIRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune pattern recognition receptors and adaptive immune receptors (PRRs and AIRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call